Helius Selling General Administrative vs Income Before Tax Analysis
HSDT Stock | USD 2.87 0.21 7.89% |
Helius Medical financial indicator trend analysis is much more than just examining Helius Medical Techn latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Helius Medical Techn is a good investment. Please check the relationship between Helius Medical Selling General Administrative and its Income Before Tax accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Selling General Administrative vs Income Before Tax
Selling General Administrative vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Helius Medical Techn Selling General Administrative account and Income Before Tax. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Helius Medical's Selling General Administrative and Income Before Tax is -0.62. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Helius Medical Technologies, assuming nothing else is changed. The correlation between historical values of Helius Medical's Selling General Administrative and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Helius Medical Technologies are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Selling General Administrative i.e., Helius Medical's Selling General Administrative and Income Before Tax go up and down completely randomly.
Correlation Coefficient | -0.62 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Selling General Administrative
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Helius Medical income statement and is an important metric when analyzing Helius Medical Techn profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from Helius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Helius Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At this time, Helius Medical's Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.02 in 2024, despite the fact that Enterprise Value is likely to grow to (225.7 K).
Helius Medical fundamental ratios Correlations
Click cells to compare fundamentals
Helius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Helius Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 15.1K | 24.0K | 49.1K | 269.9K | 607.9K | 577.5K | |
Total Assets | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Total Current Liabilities | 3.8M | 2.4M | 2.7M | 2.0M | 1.9M | 1.8M | |
Total Stockholder Equity | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.9M | |
Net Tangible Assets | 4.0M | 3.9M | 10.2M | 8.0M | 9.2M | 9.7M | |
Net Debt | (4.8M) | (3.2M) | (11.0M) | (14.4M) | (5.1M) | (5.4M) | |
Retained Earnings | (104.8M) | (118.9M) | (137.0M) | (151.1M) | (160.0M) | (152.0M) | |
Accounts Payable | 1.7M | 747K | 1.1M | 627K | 531K | 504.5K | |
Cash | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.6M | |
Cash And Short Term Investments | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.7M | |
Common Stock Total Equity | 52.2M | 26K | 31K | 1K | 900.0 | 855.0 | |
Liabilities And Stockholders Equity | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Other Current Assets | 610K | 735K | 862K | 1.2M | 1.0M | 777.2K | |
Total Liab | 4.5M | 2.7M | 2.8M | 9.1M | 5.3M | 7.1M | |
Total Current Assets | 7.2M | 4.7M | 12.6M | 16.7M | 7.3M | 9.1M | |
Short Term Debt | 172K | 59K | 3K | 54K | 45K | 42.8K | |
Common Stock | 26K | 31K | 1K | 4K | 28K | 950.0 | |
Other Current Liab | 1.5M | 1.3M | 1.4M | 1.3M | 1.3M | 1.2M | |
Net Receivables | 574K | 230K | 251K | 343K | 637K | 401.2K | |
Non Current Liabilities Total | 710K | 252K | 193K | 7.1M | 3.5M | 2.6M | |
Capital Surpluse | 6.6M | 105.4M | 111.5M | 123.9M | 142.5M | 149.6M | |
Other Stockholder Equity | 111.5M | 123.9M | 149.4M | 159.6M | 163.0M | 91.3M | |
Accumulated Other Comprehensive Income | (902K) | (1.1M) | (1.1M) | (388K) | (673K) | (706.7K) | |
Non Current Assets Total | 3.1M | 1.9M | 1.5M | 590K | 394K | 374.3K | |
Property Plant And Equipment Net | 1.3M | 576K | 412K | 450K | 230K | 418.2K | |
Net Invested Capital | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.2M | |
Property Plant And Equipment Gross | 1.3M | 576K | 412K | 450K | 589K | 631.4K | |
Net Working Capital | 3.4M | 2.3M | 9.9M | 14.7M | 5.6M | 5.8M | |
Property Plant Equipment | 1.3M | 486K | 412K | 450K | 517.5K | 612.2K | |
Inventory | 598K | 389K | 476K | 589K | 457K | 531.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.